Biotec Pharmacon: Invitation to Capital Markets Day on 11 February 2016

(Tromsø, 18 December 2015) Biotec Pharmacon ASA (OSE:Biotec) will host a Capital Markets Day (CMD) on Thursday, 11 February 2016 following the Q4 presentation.

Time: 08.30 – 11.00

Location: Hotel Continental, Stortingsgaten 24/26, Oslo

Speakers will be:
Svein Lien (CEO),
Jethro Holter (MD, ArcticZymes),
Stuart Devine (VP Marketing, Woulgan®) and
Rolf Engstad (CSO)

Breakfast will be served prior to the presentations. For practical reasons, investors, analysts and journalists coming to the event are encouraged to register via email to ir@biotec.no by 4 February 2016.

The Q4 and the CMD presentations will be webcasted live and made available on www.biotec.no and through NewsWeb on 11 February 2016.

For additional information and booking of one-to-one meetings following the CMD, please contact:

CFO
Børge Sørvoll
+47 95 29 01 87
borge.sorvoll@biotec.no

About Biotec Pharmacon ASA:

Biotec Pharmacon ASA is the parent company of Biotec BetaGlucans AS and ArcticZymes AS. Biotec BetaGlucans develops, manufactures and markets novel immunomodulating products, including Woulgan®, a premium priced product in the advanced wound care market. ArcticZymes develops, produces and markets enzymes of marine origin used in molecular DNA technologies and diagnostics, representing growth markets where rapid technological developments are creating a strong demand for new and improved enzymes.